Related references
Note: Only part of the references are listed.Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Cristina Blazquez et al.
BRAIN (2011)
Altered microRNA regulation in Huntington's disease models
Soon-Tae Lee et al.
EXPERIMENTAL NEUROLOGY (2011)
Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases
Kynan T. Lawlor et al.
HUMAN MOLECULAR GENETICS (2011)
A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression
Daniel W. Chung et al.
HUMAN MOLECULAR GENETICS (2011)
Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference
Mateusz de Mezer et al.
NUCLEIC ACIDS RESEARCH (2011)
CAG repeats mimic CUG repeats in the misregulation of alternative splicing
Agnieszka Mykowska et al.
NUCLEIC ACIDS RESEARCH (2011)
Non-ATG-initiated translation directed by microsatellite expansions
Tao Zu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Triplet Repeat-Derived siRNAs Enhance RNA-Mediated Toxicity in a Drosophila Model for Myotonic Dystrophy
Zhenming Yu et al.
PLOS GENETICS (2011)
miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts
Anna M. Eiring et al.
CELL (2010)
Expanding the MicroRNA Targeting Code: Functional Sites with Centered Pairing
Chanseok Shin et al.
MOLECULAR CELL (2010)
A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing
Eulalia Marti et al.
NUCLEIC ACIDS RESEARCH (2010)
Roles of trinucleotide-repeat RNA in neurological disease and degeneration
Ling-Bo Li et al.
TRENDS IN NEUROSCIENCES (2010)
Pathogenic mechanisms of myotonic dystrophy
Johanna E. Lee et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
Monica Banez-Coronel et al.
CURRENT CANCER DRUG TARGETS (2008)
A comparison of Huntington disease and Huntington disease-like 2 neuropathology
Dobrila D. Rudnicki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
The Bifunctional microRNA miR-9/miR-9*Regulates REST and CoREST and Is Downregulated in Huntington's Disease
Amy N. Packer et al.
JOURNAL OF NEUROSCIENCE (2008)
RNA toxicity is a component of ataxin-3 degeneration in Drosophila
Ling-Bo Li et al.
NATURE (2008)
A microRNA-based gene dysregulation pathway in Huntington's disease
Rory Johnson et al.
NEUROBIOLOGY OF DISEASE (2008)
Systematic Identification of mRNAs Recruited to Argonaute 2 by Specific microRNAs and Corresponding Changes in Transcript Abundance
David G. Hendrickson et al.
PLOS ONE (2008)
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies
Jeffrey N. Savas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Huntington's disease-like 2 is associated with CUG repeat-containing RNA foci
Dobrila D. Rudnicki et al.
ANNALS OF NEUROLOGY (2007)
Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets
Jacelk Krol et al.
MOLECULAR CELL (2007)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
Control of translation and mRNA degradation by miRNAs and siRNAs
MA Valencia-Sanchez et al.
GENES & DEVELOPMENT (2006)
Diseases of unstable repeat expansion: Mechanisms and common principles
JR Gatchel et al.
NATURE REVIEWS GENETICS (2005)
Post-transcriptional gene silencing by siRNAs and miRNAs
W Filipowicz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2005)
Expression pattern of apoptosis-related markers in Huntington's disease
JC Vis et al.
ACTA NEUROPATHOLOGICA (2005)
Specificity of microRNA target selection in translational repression
JG Doench et al.
GENES & DEVELOPMENT (2004)
Argonaute2 is the catalytic engine of mammalian RNAi
JD Liu et al.
SCIENCE (2004)
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
G Meister et al.
MOLECULAR CELL (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists
SP Presgraves et al.
NEUROTOXICITY RESEARCH (2004)
Pathogenic RNA repeats: an expanding role in genetic disease
LPW Ranum et al.
TRENDS IN GENETICS (2004)
RNA structure of trinucleotide repeats associated with human neurological diseases
K Sobczak et al.
NUCLEIC ACIDS RESEARCH (2003)
The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer
V Handa et al.
NUCLEIC ACIDS RESEARCH (2003)
Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders
CA Ross
NEURON (2002)
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2002)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
A Wyttenbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
